At a glance
ClinicalIndex Comparison RecordN/ACompleted· 58 enrolled
Drug / intervention
Liver Transplantprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Superior Vena Cava (SVC) Diameter and Collapsibility Index and Its Relationship to Central Venous Pressure (CVP) Measurements in Patients Undergoing Liver Transplantation
In Brief
An observational study evaluating Liver Transplant for Liver Failure. Completed, enrolled 58 participants across 1 site.
Detailed Summary
Consecutive patients undergoing liver transplant surgery will be included in the study. Before surgical incision, during the preanhepatic phase, during the anhepatic phase, during the postanhepatic phase and following closure of the deep fascial layer of the anterior abdominal wall simultaneous measurement of SVC diameter, SBC collapsibility index and CVP will be recorded.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Failure
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 2016
Enrollment StartJul 2016
Primary CompletionMay 2019
Study CompletionSep 2020
TodayJul 2026
First PostedJun 29, 2016
Enrollment StartJul 1, 2016
Primary CompletionMay 1, 2019
Study CompletionSep 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 10.0 years ago
Interventions
Liver Transplantprocedure
liver transplant recipient surgery